KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Non-cash Items (2018 - 2025)

Historic Non-cash Items for Staar Surgical (STAA) over the last 11 years, with Q3 2025 value amounting to $3.3 million.

  • Staar Surgical's Non-cash Items fell 7331.17% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 7331.17%. This contributed to the annual value of $4.0 million for FY2024, which is 6073.55% down from last year.
  • As of Q3 2025, Staar Surgical's Non-cash Items stood at $3.3 million, which was down 7331.17% from $1.2 million recorded in Q2 2025.
  • Staar Surgical's 5-year Non-cash Items high stood at $203.1 million for Q1 2021, and its period low was $1.2 million during Q2 2025.
  • For the 5-year period, Staar Surgical's Non-cash Items averaged around $16.8 million, with its median value being $2.0 million (2022).
  • As far as peak fluctuations go, Staar Surgical's Non-cash Items tumbled by 9908.27% in 2021, and later skyrocketed by 232104.13% in 2022.
  • Over the past 5 years, Staar Surgical's Non-cash Items (Quarter) stood at $1.9 million in 2021, then soared by 2321.04% to $45.1 million in 2022, then tumbled by 77.63% to $10.1 million in 2023, then plummeted by 60.74% to $4.0 million in 2024, then decreased by 17.09% to $3.3 million in 2025.
  • Its Non-cash Items was $3.3 million in Q3 2025, compared to $1.2 million in Q2 2025 and $2.0 million in Q1 2025.